Zoltán Marcsek

Summary

Affiliation: National Center for Epidemiology
Country: Hungary

Publications

  1. ncbi The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment
    Zoltán Marcsek
    National Institute of Chemical Safety, Jozsef Fodor National Center for Public Health, Budapest, Hungary
    Cancer Biother Radiopharm 19:746-53. 2004
  2. ncbi Effect of simultaneous administration of Avemar and cytostatic drugs on viability of cell cultures, growth of experimental tumors, and survival tumor-bearing mice
    Bela Szende
    National Institute of Chemical Safety, Jozsef Fodor National Center for Public Health, 1450 Budapest, Hungary
    Cancer Biother Radiopharm 19:343-9. 2004

Detail Information

Publications2

  1. ncbi The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment
    Zoltán Marcsek
    National Institute of Chemical Safety, Jozsef Fodor National Center for Public Health, Budapest, Hungary
    Cancer Biother Radiopharm 19:746-53. 2004
    ..As apoptosis increased when Avemar was added to tamoxifen treatment, the use of supplementary therapy with Avemar in the case of ER+ breast tumors may enhance the therapeutic effects of tamoxifen...
  2. ncbi Effect of simultaneous administration of Avemar and cytostatic drugs on viability of cell cultures, growth of experimental tumors, and survival tumor-bearing mice
    Bela Szende
    National Institute of Chemical Safety, Jozsef Fodor National Center for Public Health, 1450 Budapest, Hungary
    Cancer Biother Radiopharm 19:343-9. 2004
    ..Avemar may be administered together with cytostatic drugs, without the risk of increasing toxicity or decreasing antiproliferative activity...